US-Iran war CJP protest in Delhi US-Saudi nuclear deal Commonwealth Games 2026 Wildfires in Europe

Biological E's Corbevax price cut to Rs 250 per dose for private centres

Earlier, in private vaccination centres the overall cost to end-users of the vaccine was Rs 990 a dose, including taxes and administration charges

|May 16, 2022, 17:02:46 IST

New Delhi: Pharmaceuticals firm Biological E today said it has reduced the price of its COVID-19 vaccine Corbevax to Rs 250 from Rs 840 a dose, inclusive of goods and services tax, for private vaccination centres.It would result in end-users paying Rs 400 a dose, including taxes and administration charges, the company said in a statement.Previously, in private vaccination centres the overall cost to end-users of the vaccine was Rs 990 a dose, including taxes and administration charges, it added.In March this year when the inoculation of children in the age group of 12 to 14 years started in India, Corbevax vaccine was used and its price was fixed at ₹ 145 for the government's vaccination programme."BE has lowered the price of its vaccine with the aim of making it more affordable and help increase the reach to protect the maximum number of children against the virus," the company said.Read all the Latest News, Trending News, Cricket News, Bollywood News,India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.

10,000 steps a day is not enough: Top doctor explains the role of timing

Walking 10,000 steps a day is beneficial, but experts say timing matters. Short walks after meals and breaking up long periods of sitting may be more effective for blood sugar control and overall metabolic health

3 min read

What happens when you stop drinking tea for 30 days? Doctor explains the effects

Thinking of quitting tea for a month? Experts explain how cutting out caffeine can affect your body, from withdrawal symptoms in the first week to better sleep and improved iron absorption over time.

2 min read

Stroke is rising among young adults. Doctor explains why it's happening and what you must do

Stroke is increasingly affecting adults in their 30s, 40s and 50s. Experts say unhealthy lifestyles, undiagnosed high blood pressure and delayed treatment are driving the rise in younger stroke cases

3 min read

Stroke in young adults, silent symptoms and late diagnosis: India's growing brain health challenge

Neurologists warn that stroke is increasingly affecting people in their 30s and 40s, while many brain disorders progress silently before symptoms appear. They say early diagnosis, timely referrals and healthier lifestyles are key to reducing India's growing neurological disease burden.

5 min read

Brain tumours aren't always fatal, but delayed diagnosis can be: Experts explain the key warning signs

Brain tumours are frequently mistaken for common headaches, stress or age-related cognitive changes. Doctors say recognising warning signs early and adopting a brain-healthy lifestyle can improve outcomes and reduce the risk of long-term neurological complications.